Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Immune Infiltrate”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Not applicableUnknownNCT01688232
What this trial is testing

The Immunoscore as a Prognostic Marker for Patients With a Colorectal Cancer

Who this might be right for
Colorectal CancerSurgical Resection of the Colorectal Tumor
Assistance Publique - Hôpitaux de Paris 459
Not applicableStudy completedNCT07528911
What this trial is testing

Elements of Adaptive Immunity in Epithelial Ovarian Cancer

Who this might be right for
Epithelial High Grade Serous Ovarian Cancer
Hellenic Cooperative Oncology Group 687
Testing effectiveness (Phase 2)UnknownNCT04262687
What this trial is testing

Chemotherapy and Immunotherapy as Treatment for MSS Metastatic Colorectal Cancer With High Immune Infiltrate

Who this might be right for
Colorectal Cancer MetastaticHigh Immune InfiltrateMicrosatellite Stable
Federation Francophone de Cancerologie Digestive 55
Testing effectiveness (Phase 2)Looking for participantsNCT06630611
What this trial is testing

Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)

Who this might be right for
MelanomaNon Small Cell Lung CancerCervical Cancer
Vall d'Hebron Institute of Oncology 40
Testing effectiveness (Phase 2)Looking for participantsNCT04114136
What this trial is testing

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

Who this might be right for
MelanomaNSCLCHepatocellular Carcinoma+5 more
Dan Zandberg 72
Not applicableStudy completedNCT04726735
What this trial is testing

Evaluation of PD-L1 Expression and Immune Infiltration in High-risk Non Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
University Hospital, Bordeaux 100
Testing effectiveness (Phase 2)Looking for participantsNCT07109323
What this trial is testing

Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM

Who this might be right for
Ultra High Risk mm (uhr-mm), 18-70 Years Old, Suitable for ASCT. And Meet Any of the Following uhr-mm DefinitionsCytogenetics Ultra High RiskPrimary Refractory+4 more
Institute of Hematology & Blood Diseases Hospital, China 50
Large-scale testing (Phase 3)Ended earlyNCT03233828
What this trial is testing

Pre-Treatment of Highly Suspicious Pigmented Skin Lesions With Interleukin-2

Who this might be right for
Melanoma (Skin)Melanoma in Situ
Carman Giacomantonio 1
Not applicableEnrolling By InvitationNCT06646263
What this trial is testing

Cellular Immune Responses in Triple-negative Breast Cancer - High Throughput Immunogenetic Studies

Who this might be right for
Triple Negative Breast Cancer
Institute of Applied Biosciences 150
Testing effectiveness (Phase 2)Study completedNCT01858558
What this trial is testing

Tadalafil and Lenalidomide Maintenance With or Without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma

Who this might be right for
Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 102